U.S. Could Speed Device Innovation Through Clinical Research Reforms

A focus on FDA regulations alone will not reverse the trend of device innovation efforts moving overseas, clinical investigators and regulators said last week at the Cardiovascular Research Technologies meeting in Washington, D.C.